Neurogenin 3-specific dipeptidyl peptidase-2 deficiency causes impaired glucose tolerance, insulin resistance, and visceral obesity

Endocrinology

Volumn 150, Issue 12, 2009, Pages 5240-5248

  Danilova, Olga V ^a   Tai, Albert K ^a   Mele, Deanna A ^a   Beinborn, Martin ^b   Leiter, Andrew B ^e   Greenberg, Andrew S ^d   Perfield II, James W ^d,f   DeFuria, Jason ^d   Singru, Praful S ^c   Lechan, Ronald M ^c   Huber, Brigitte T ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Tupper Research Institute   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d TUFTS UNIVERSITY   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE; DIPEPTIDYL PEPTIDASE 2; DIPEPTIDYL PEPTIDASE IV; NEUROGENIN 3; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIPEPTIDYL PEPTIDASE 2 DEFICIENCY; ENZYME ACTIVITY; ENZYME DEFICIENCY; FATTY LIVER; FOOD INTAKE; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIPID DIET; LUNG GAS EXCHANGE; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL;

ADIPOSE TISSUE; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOOD GLUCOSE; DIPEPTIDYL-PEPTIDASES AND TRIPEPTIDYL-PEPTIDASES; EATING; FASTING; FATTY LIVER; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE INTOLERANCE; INSULIN; INSULIN RESISTANCE; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; OBESITY;

EID: 71949092942     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0386     Document Type: Article

References (38)

1. Bartness TJ, Song CK 2007 Brain-adipose tissue neural crosstalk. Physiol Behav 91:343-351
2. Gurevich-Panigrahi T, Panigrahi S, Wiechec E, Los M 2009 Obesity: pathophysiology and clinical management. Curr Med Chem 16:506-521
3. Baggio L, Kieffer TJ, Drucker DJ 2000 Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, regulates fasting glycemia and nonenteral glucose clearance in mice. Endocrinology 141:3703-3709 (Pubitemid 30815694)
4. Mentlein R, Gallwitz B, Schmidt WE 1993 Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem 214:829-835 (Pubitemid 23188160)
5. Deacon CF, Johnsen AH, Holst JJ 1995 Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. J Clin Endocrinol Metab 80:952-957
6. Baggio LL, Drucker DJ 2002 Harnessing the therapeutic potential of glucagon-like peptide-1: a critical review. Treat Endocrinol 1:117-125
7. Kim JG, Baggio LL, Bridon DP, Castaigne JP, Robitaille MF, Jetté L, Benquet C, Drucker DJ 2003 Development and characterization of a glucagon-like peptide 1-albumin conjugate: the ability to activate the glucagon-like peptide 1 receptor in vivo. Diabetes 52:751-759 (Pubitemid 36323583)
8. Ahrén B 2008 Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes. Expert Opin Emerg Drugs 13:593-607
9. Underwood R, Chiravuri M, Lee H, Schmitz T, Kabcenell AK, Yardley K, Huber BT 1999 Sequence, purification, and cloning of an intracellular serine protease, quiescent cell proline dipeptidase. J Biol Chem 274:34053-34058 (Pubitemid 129511738)
10. Chiravuri M, Agarraberes F, Mathieu SL, Lee H, Huber BT 2000 Vesicular localization and characterization of a novel post-proline-cleaving aminodipeptidase, quiescent cell proline dipeptidase. J Immunol 165:5695-5702 (Pubitemid 30836181)
11. Rosenblum JS, Kozarich JW 2003 Prolyl peptidases: a serine protease subfamily with high potential for drug discovery. Curr Opin Chem Biol 7:496-504
12. Maes MB, Lambeir AM, Gilany K, Senten K, Van der Veken P, Leiting B, Augustyns K, Scharpé S, De Meester I 2005 Kinetic investigation of human dipeptidyl peptidase II (DPPII)-mediated hydrolysis of dipeptide derivatives and its identification as quiescent cell proline dipeptidase (QPP)/dipeptidyl peptidase 7 (DPP7). Biochem J 386:315-324
13. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR 2002 Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418:650-654 (Pubitemid 34886868)
14. Lin S, Boey D, Herzog H 2004 NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides 38:189-200 (Pubitemid 39161911)
15. Schonhoff SE, Giel-Moloney M, Leiter AB 2004 Neurogenin 3-expressing progenitor cells in the gastrointestinal tract differentiate into both endocrine and non-endocrine cell types. Dev Biol 270:443-454 (Pubitemid 38748564)
16. Marguet D, Baggio L, Kobayashi T, Bernard AM, Pierres M, Nielsen PF, Ribel U, Watanabe T, Drucker DJ, Wagtmann N 2000 Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26. Proc Natl Acad Sci USA 97:6874-6879 (Pubitemid 30412807)
17. Conarello SL, Li Z, Ronan J, Roy RS, Zhu L, Jiang G, Liu F, Woods J, Zycband E, Moller DE, Thornberry NA, Zhang BB 2003 Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance. Proc Natl Acad Sci USA 100:6825-6830 (Pubitemid 36666664)
18. Ventura A, Meissner A, Dillon CP, McManus M, Sharp PA, Van Parijs L, Jaenisch R, Jacks T 2004 Cre-lox-regulated conditional RNA interference from transgenes. Proc Natl Acad Sci USA 101:10380-10385 (Pubitemid 38924934)
19. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, Rooney DL, Zhang M, Ihrig MM, McManus MT, Gertler FB, Scott ML, Van Parijs L 2003 A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33:401-406 (Pubitemid 36278858)
20. Wakeland E, Morel L, Achey K, Yui M, Longmate J 1997 Speed congenics: a classic technique in the fast lane (relatively speaking). Immunol Today 18:472-477 (Pubitemid 27441589)
21. Beinborn M, Worrall CI, McBride EW, Kopin AS 2005 A human glucagon-like peptide-1 receptor polymorphism results in reduced agonist responsiveness. Regul Pept 130:1-6 (Pubitemid 40966015)
22. Watanabe K, Beinborn M, Nagamatsu S, Ishida H, Takahashi S 2005 Menetrier's disease in a patient with Helicobacter pylori infection is linked to elevated glucagon-like peptide-2 activity. Scand J Gastroenterol 40:477-481
23. Mele D, Bista P, Baez DV, Huber BT 2009 Dipeptidyl peptidase 2 is an essential survival factor in the regulation of cell quiescence. Cell Cycle 8:2425-2434
24. Shi H, Strader AD, Woods SC, Seeley RJ 2007 The effect of fat removal on glucose tolerance is depot specific in male and female mice. Am J Physiol Endocrinol Metab 293:E1012-E1020 (Pubitemid 47535832)
25. Macotela Y, Boucher J, Tran TT, Kahn CR 2009 Gender and depot differences in adipocyte insulin sensitivity and glucose metabolism. Diabetes 58:803-812
26. Valera Mora ME, Scarfone A, Calvani M, Greco AV, Mingrone G 2003 Insulin clearance in obesity. J Am Coll Nutr 22:487-493
27. Wren AM, Bloom SR 2007 Gut hormones and appetite control. Gastroenterology 132:2116-2130
28. Hamdy O, Porramatikul S, Al-Ozairi E 2006 Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2:367-373 (Pubitemid 44734225)
29. Strissel KJ, Stancheva Z, Miyoshi H, Perfield 2nd JW, DeFuria J, Jick Z, Greenberg AS, Obin MS 2007 Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 56:2910-2918 (Pubitemid 350223625)
30. Browning JD, Horton JD 2004 Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114:147-152 (Pubitemid 39071617)
31. Frerker N, Wagner L, Wolf R, Heiser U, Hoffmann T, Rahfeld JU, Schade J, Karl T, Naim HY, Alfalah M, Demuth HU, von Hörsten S 2007 Neuropeptide Y (NPY) cleaving enzymes: structural and functional homologues of dipeptidyl peptidase 4. Peptides 28:257-268 (Pubitemid 46188365)
32. Merali Z, McIntosh J, Anisman H 1999 Role of bombesin-related peptides in the control of food intake. Neuropeptides 33:376-386 (Pubitemid 29530130)
33. McGowan BM, Stanley SA, Smith KL, White NE, Connolly MM, Thompson EL, Gardiner JV, Murphy KG, Ghatei MA, Bloom SR 2005 Central relaxin-3 administration causes hyperphagia in male Wistar rats. Endocrinology 146:3295-3300
34. Oh-I S, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, Eguchi H, Yamamoto M, Imaki T, Hashimoto K, Tsuchiya T, Monden T, Horiguchi K, Yamada M, Mori M 2006 Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 443:709-712 (Pubitemid 44564715)
35. Brailoiu GC, Dun SL, Brailoiu E, Inan S, Yang J, Chang JK, Dun NJ 2007 Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology 148:5088-5094 (Pubitemid 47481535)
36. Lebrun B, Bariohay B, Moyse E, Jean A 2006 Brain-derived neurotrophic factor (BDNF) and food intake regulation: a minireview. Auton Neurosci 126-127:30-38 (Pubitemid 43833352)
37. Karagiannides I, Torres D, Tseng YH, Bowe C, Carvalho E, Espinoza D, Pothoulakis C, Kokkotou E 2008 Substance P as a novel anti-obesity target. Gastroenterology 134:747-755
38. Matsuda K, Maruyama K 2007 Regulation of feeding behavior by pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) in vertebrates. Peptides 28:1761-1766 (Pubitemid 47361411)